BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
‘Uncanny Valley’: Iran’s Threats on US Tech, Trump’s Plans for Midterms, and Polymarket’s Pop-up Flop
Kate Knibbs: So, you went twice? Makena Kelly: Sure, Kate. I went twice. Kate Knibbs: I missed that. Zoë Schiffer:…
Last Rites’ Star Patrick Wilson Believe In The Paranormal?
Patrick Wilson, Ben Hardy and Vera Farmiga in “The Conjuring Last Rites.” Warner Bros. Pictures/New Line Cinema After playing Ed…
Is Creator Studio Apple’s Trojan Horse Into Adobe’s Market?
Apple’s new Creator Studio bundles pro-grade instruments right into a low-cost subscription, altering how creators method paid software program. It…